Cannabinoids for People with ASD: A Systematic Review of Published and Ongoing Studies.
THC
autism spectrum disorder
cannabidiol
cannabidivarin
cannabinoids
epilepsy
hyperactivity
problem behaviors
side effects
sleep
Journal
Brain sciences
ISSN: 2076-3425
Titre abrégé: Brain Sci
Pays: Switzerland
ID NLM: 101598646
Informations de publication
Date de publication:
20 Aug 2020
20 Aug 2020
Historique:
received:
15
07
2020
revised:
15
08
2020
accepted:
17
08
2020
entrez:
23
8
2020
pubmed:
23
8
2020
medline:
23
8
2020
Statut:
epublish
Résumé
The etiopathogenesis of autism spectrum disorder (ASD) remains largely unclear. Among other biological hypotheses, researchers have evidenced an imbalance in the endocannabinoid (eCB) system, which regulates some functions typically impaired in ASD, such as emotional responses and social interaction. Additionally, cannabidiol (CBD), the non-intoxicating component of
Identifiants
pubmed: 32825313
pii: brainsci10090572
doi: 10.3390/brainsci10090572
pmc: PMC7563787
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Références
J Psychopharmacol. 2019 Sep;33(9):1141-1148
pubmed: 31237191
Psychopharmacology (Berl). 2014 Aug;231(15):3009-17
pubmed: 24577515
Brain Sci. 2020 Mar 13;10(3):
pubmed: 32182969
J Gen Intern Med. 2019 Oct;34(10):1992-1994
pubmed: 31144278
J Clin Psychiatry. 2009 Jul;70(7):1041-50
pubmed: 19653979
Neurotox Res. 2011 Feb;19(2):286-307
pubmed: 20607469
Pediatrics. 2014 Jan;133(1):e54-63
pubmed: 24323995
Int J Mol Sci. 2017 Sep 07;18(9):
pubmed: 28880200
PLoS Med. 2009 Jul 21;6(7):e1000097
pubmed: 19621072
PLoS One. 2016 Apr 11;11(4):e0153327
pubmed: 27065006
Eur Child Adolesc Psychiatry. 2017 Sep;26(9):1093-1103
pubmed: 28674760
Neuron. 2015 Aug 19;87(4):684-98
pubmed: 26291155
Neuropsychopharmacology. 2019 Jul;44(8):1398-1405
pubmed: 30758329
Nat Genet. 2019 Mar;51(3):431-444
pubmed: 30804558
Neuroscience. 2016 May 3;321:24-41
pubmed: 26577932
Am J Perinatol. 2017 Feb;34(3):295-304
pubmed: 28099978
Front Neurosci. 2016 May 10;10:192
pubmed: 27242398
Lancet Psychiatry. 2019 Oct;6(10):819-829
pubmed: 31447415
J Psychopharmacol. 2018 Jan;32(1):3-29
pubmed: 29237331
Biol Psychiatry. 2017 May 15;81(10):838-847
pubmed: 27450033
Nutr Metab (Lond). 2011 Jun 08;8(1):34
pubmed: 21651783
Epilepsia. 2018 Jul;59(7):1316-1326
pubmed: 29858515
Lancet. 2014 Mar 8;383(9920):896-910
pubmed: 24074734
Neurochem Res. 2005 Aug;30(8):1037-43
pubmed: 16258853
Psychopharmacology (Berl). 2013 Mar;226(1):13-24
pubmed: 23007604
Sci Rep. 2019 Jan 17;9(1):200
pubmed: 30655581
Int J Mol Sci. 2020 Jan 22;21(3):
pubmed: 31979108
Molecules. 2019 Apr 12;24(8):
pubmed: 31013866
BMC Psychiatry. 2011 Dec 15;11:197
pubmed: 22171594
Mol Autism. 2018 Mar 12;9:18
pubmed: 29564080
Neuropsychiatr Dis Treat. 2017 Dec 18;14:1-10
pubmed: 29296085
J Child Adolesc Psychopharmacol. 2011 Dec;21(6):517-35
pubmed: 22166172
Transl Psychiatry. 2019 Nov 20;9(1):313
pubmed: 31748505
Neuropharmacology. 2016 Apr;103:16-26
pubmed: 26711860
Brain Sci. 2020 May 31;10(6):
pubmed: 32486513
Front Pharmacol. 2019 Jan 09;9:1521
pubmed: 30687090
Transl Psychiatry. 2016 Sep 27;6(9):e902
pubmed: 27676443
Neurotherapeutics. 2015 Oct;12(4):837-47
pubmed: 26216231
Neurol Int. 2010 Jun 21;2(1):e10
pubmed: 21577334
Neurosci Biobehav Rev. 2017 Apr;75:157-165
pubmed: 28185872
BMC Psychiatry. 2019 Oct 29;19(1):328
pubmed: 31664964
MMWR Surveill Summ. 2020 Mar 27;69(4):1-12
pubmed: 32214087
Eur Neuropsychopharmacol. 2017 Aug;27(8):795-808
pubmed: 28576350
Mol Autism. 2019 Jan 30;10:2
pubmed: 30728928
J Clin Med. 2019 Feb 08;8(2):
pubmed: 30744008
Psychol Med. 2015 Feb;45(3):601-13
pubmed: 25108395
Prog Brain Res. 2002;135:419-27
pubmed: 12143360
Lancet Psychiatry. 2019 Jul;6(7):590-600
pubmed: 31230684
Br J Pharmacol. 2012 Dec;167(8):1629-42
pubmed: 22970845
J Am Pharm Assoc (2003). 2020 Jan - Feb;60(1):253-261
pubmed: 31866386
Autism. 2020 Feb;24(2):274-284
pubmed: 31269800
Psychol Med. 2019 Mar;49(4):559-572
pubmed: 30178724
J Autism Dev Disord. 2020 Nov;50(11):3857-3873
pubmed: 32297123
Eur J Neurosci. 2018 Mar;47(6):534-548
pubmed: 28452083
Res Autism Spectr Disord. 2014 Sep 1;8(9):1121-1133
pubmed: 25221619
Int J Neuropsychopharmacol. 2006 Jun;9(3):277-86
pubmed: 15967059
J Autism Dev Disord. 2016 Mar;46(3):825-39
pubmed: 26443675
J Autism Dev Disord. 2019 Mar;49(3):1284-1288
pubmed: 30382443
Ther Adv Psychopharmacol. 2019 Nov 08;9:2045125319881916
pubmed: 31741731
Psychiatry Res. 2019 Jun;276:203-209
pubmed: 31102885
Behav Brain Res. 2013 Jul 15;249:124-32
pubmed: 23643692
J Psychopharmacol. 2019 Jul;33(7):894-907
pubmed: 31084246
Medicine (Baltimore). 2017 May;96(18):e6696
pubmed: 28471964
Front Psychiatry. 2019 Sep 12;10:658
pubmed: 31572239
Epilepsy Behav. 2019 Sep;98(Pt A):238-248
pubmed: 31398688
J Child Neurol. 2014 Nov;29(11):1554-61
pubmed: 24097852
J Psychopharmacol. 2013 Mar;27(3):312-6
pubmed: 23343597
Psychopharmacology (Berl). 2014 Mar;231(6):999-1009
pubmed: 24005531
Neuropsychopharmacology. 2017 Jun;42(7):1447-1457
pubmed: 28230072
Prog Neuropsychopharmacol Biol Psychiatry. 2019 Mar 8;89:90-96
pubmed: 30171992
Am J Health Syst Pharm. 2008 Jun 1;65(11):1029-38
pubmed: 18499875
Ann Pharmacother. 2019 Jun;53(6):603-611
pubmed: 30616356
Curr Psychiatry Rep. 2014 Mar;16(3):437
pubmed: 24488702
Front Neurol. 2019 Oct 31;10:1145
pubmed: 31736860
Genes Brain Behav. 2003 Oct;2(5):255-67
pubmed: 14606691